Skip to main content
Premium Trial:

Request an Annual Quote

Ambion Gets $10.5M Financing for RNA Research

NEW YORK, May 1 - RNA provider Ambion has raised $10.5 million in a private financing, the company said today.

 

The financing was led by VC firm Telegraph Hill Partners, of San Francisco. Consequently, Ambion has appointed J. Matthew Mackowski of Telegraph Hill to its Board of Directors.

 

The company is planning to use the financing to grow its business in RNA research, including clinical applications of RNA, Ambion CEO Matt Winkler said in a statement.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.